Skip to main content
Caplight Logo









Beijing Datsing Bio-Tech Co., Ltd.

Beijing Datsing Bio-Tech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.datsing.com/

Last Round

Private Equity

Jul 10, 2026

Total Funding Raised

$20.62M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Beijing Datsing Bio-Tech Co., Ltd. is a biotechnology company that develops, manufactures, and markets medical products for wound management, minimally invasive surgery, stomatology, and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biomedical materialshemostatic materialregenerative medicinetissue engineeringmedical consumablesbone graftdental desensitizersurgical suppliesbiocompatible materialswound managementminimally invasive surgerybiotech manufacturingmedtechsurgical sealantorthopedic consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Datsing Bio-Tech Co., Ltd. Comparables

Compare Beijing Datsing Bio-Tech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Datsing Bio-Tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Success Bio-Tech Co., Ltd.
87%
CuraMedical B.V.
84%
Hangzhou Singclean Medical Products Co., Ltd.
84%

Beijing Datsing Bio-Tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 10, 2026
Series CJan 1, 2019
Series BAug 1, 2014
Series AMay 1, 2013
SeedSep 1, 2009

Beijing Datsing Bio-Tech Co., Ltd. Investors

Notable investors and investment history

Beijing Datsing Bio-Tech Co., Ltd. investors
InvestorRounds
Northern Light Venture CapitalSeries B
China Science and Technology Industry Investment ManagementSeries C
Tsinghua Innovation VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 10, 2026

    $9.24M round led by Nanjing Pharmaceutical Group Company Limited.

  • Jan 1, 2019

    Raised Series C round with China Science and Technology Industry Investment Management.

Beijing Datsing Bio-Tech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Datsing Bio-Tech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Datsing Bio-Tech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range27
Year Founded2001
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?